관절내 보충 요법 시장 : 유형별, 연령층별, 유통 채널별, 용도별, 최종 용도별, 지역별(2025-2033년)
Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2025-2033
상품코드:1675361
리서치사:IMARC
발행일:2025년 03월
페이지 정보:영문 143 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 관절내 보충 요법 시장 규모는 2024년에 48억 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 91억 달러에 달하며, 2025-2033년의 성장률(CAGR)은 7.05%에 달할 것으로 예측하고 있습니다. 골다공증과 골관절염(OA)의 유병률 증가와 저침습 비외과적 치료에 대한 소비자 경향의 변화가 시장을 촉진하는 주요 요인의 일부입니다.
인공관절 치환술은 외인성 히알루론산(HA) 유도체로 알려진 젤 형태의 액체를 함유한 관절내 주사를 환자의 무릎 관절에 직접 투여하는 최소 침습적 의료 시술입니다. 이는 윤활유 역할을 하여 뼈와 뼈가 서로 원활하게 움직일 수 있도록 돕고, 염증을 억제하며, 관절 하중에 대한 충격 흡수제 역할을 합니다. 관절내 보충 요법은 운동 중 마찰을 줄이고 활액이 쿠션을 만들어 심한 통증을 없애고 관절의 운동 범위와 움직임을 증가시키는 데 도움이 됩니다. 이 외에도 활액의 유변학적 특성을 회복시켜 기계적 효과, 진통 효과, 항염증 효과, 연골 보호 효과를 가져옵니다. 그 결과, 관절내 치환술은 슬관절증, 고관절증, 수부관절증 치료에 널리 이용되고 있습니다. 현재, 주로 중분자량, 저분자량, 고분자량 제품을 사용할 수 있습니다.
관절내 보충 요법 시장 동향 :
골다공증과 골관절염(OA)의 유병률 증가는 시장 성장을 이끄는 중요한 요인 중 하나입니다. 이에 따라 저침습적 비수술적 치료법에 대한 소비자의 선호도가 높아지면서 부신피질 스테로이드와 관절통 관리를 위한 관절내 치환술이 헬스케어 분야에서 널리 채택되고 있습니다. 이는 또 다른 큰 성장 촉진요인으로 작용하고 있습니다. 또한 비수술적 치료의 장점인 입원 불필요, 적은 비용, 적은 합병증, 높은 임상 결과와 회복률 등에 대한 소비자의 인식이 높아진 것도 영향을 미치고 있습니다. 또한 정부의 적극적인 노력과 신약 출시 및 다양한 투여 경로에 대한 제약사들의 막대한 투자가 시장 성장을 지원하고 있습니다. 또한 관절, 인대, 근육, 척추, 신경 등 신체의 다양한 부위의 외과적 및 비외과적 문제를 해결하기 위한 집중 치료를 제공하는 외래수술센터(ASC)(ACS)의 출현이 시장 성장을 가속하고 있습니다. 또한 수압 산을 이용한 비맹검 단일 주사의 도입은 시장 성장을 가속하고 있습니다. 이 외에도 유리한 의료 보험 상환 정책, 만성질환에 취약한 노인 인구 증가, 만성 장애인 증가, 주요 기업 간의 협력 및 제휴, 의료 과학 분야의 지속적인 연구개발(R&D) 활동 등이 시장 성장에 긍정적인 영향을 미치고 있습니다.
The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.
Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.
Viscosupplementation Market Trends:
The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.
Key Market Segmentation:
Type Insights:
Single Injection
Three Injection
Five Injection
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.
Age Group Insights:
Adults
Geriatrics
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
Application Insights:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Others
End Use Insights:
Hospitals
Orthopedic Clinics
Others
The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.
Key Questions Answered in This Report:
How has the global viscosupplementation market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global viscosupplementation market?
What are the key regional markets?
Which countries represent the most attractive viscosupplementation markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What is the competitive structure of the global viscosupplementation market?
Who are the key players/companies in the global viscosupplementation market?
